Statin-induced myalgia and myositis: an update on pathogenesis and clinical recommendations

HMG CoA reductase inhibitor associated myositis and autoimmune hepatitis

(2017) Dharmenaan Palamuthusingam et al.   INTERNAL MEDICINE JOURNAL

Statin-Associated Autoimmune Myopathy

(2017) Salik Nazir et al.   JCR-JOURNAL OF CLINICAL RHEUMATOLOGY

Statin-associated muscle symptoms—Managing the highly intolerant

(2017) James M. Backes et al.   Journal of Clinical Lipidology

Anti-HMGCR Autoantibodies in Juvenile Idiopathic Inflammatory Myopathies Identify a Rare but Clinically Important Subset of Patients

(2017) Sarah L. Tansley et al.   JOURNAL OF RHEUMATOLOGY

Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase

(2017) Ajay Gupta et al.   LANCET

PCSK9 Inhibition to Reduce Cardiovascular Events

(2017) Robin P.F. Dullaart   NEW ENGLAND JOURNAL OF MEDICINE

Association of Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Autoantibodies With DRB1*07:01 and Severe Myositis in Juvenile Myositis Patients

(2017) Takayuki Kishi et al.   ARTHRITIS CARE & RESEARCH

Statin-associated autoimmune myopathy: A distinct new IFL pattern can increase the rate of HMGCR antibody detection by clinical laboratories

(2016) M. Alvarado-Cardenas et al.   AUTOIMMUNITY REVIEWS

High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody

(2016) Yves Allenbach et al.   BRAIN

Diagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance: Canadian Consensus Working Group Update (2016)

(2016) G.B. John Mancini et al.   CANADIAN JOURNAL OF CARDIOLOGY

HMGCR-associated myositis: a New Zealand case series and estimate of incidence

(2016) N. Kennedy et al.   INTERNAL MEDICINE JOURNAL

Interpretation of the evidence for the efficacy and safety of statin therapy

(2016) Rory Collins et al.   LANCET

Absence of anti-HMG-CoA reductase autoantibodies in severe self-limited statin-related myopathy

(2016) James S. Floyd et al.   MUSCLE & NERVE

Statin-Associated Autoimmune Myopathy

(2016) Andrew L. Mammen   NEW ENGLAND JOURNAL OF MEDICINE

Pediatric necrotizing myopathy associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies

(2016) Wen-Chen Liang et al.   RHEUMATOLOGY

Atorvastatin-induced dermatomyositis in a 47-year-old woman with Sjögren’s syndrome

(2015) Eri Komai et al.   ACTA CARDIOLOGICA

Genetic and immunologic susceptibility to statin-related myopathy

(2015) Jaideep Patel et al.   ATHEROSCLEROSIS

Muscle-related side-effects of statins

(2015) Beth A. Taylor et al.   CURRENT OPINION IN LIPIDOLOGY

Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management

(2015) Erik S. Stroes et al.   EUROPEAN HEART JOURNAL

Statins and myositis: the role of anti-HMGCR antibodies

(2015) Albert Selva-O’Callaghan et al.   Expert Review of Clinical Immunology

Estatinas y autoinmunidad

(2015) Marcelo Alvarado Cárdenas et al.   MEDICINA CLINICA

Statins and Myotoxic Effects Associated With Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Autoantibodies

(2015) Yurika Watanabe et al.   MEDICINE

Clinical and genetic associations of autoantibodies to 3-hydroxy-3-methyl-glutaryl-coenzyme a reductase in patients with immune-mediated myositis and necrotizing myopathy

(2015) Vidya Limaye et al.   MUSCLE & NERVE

Intravenous Immune Globulin for Statin-Triggered Autoimmune Myopathy

(2015) Andrew L. Mammen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinical Characteristics of Anti-3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Antibodies in Chinese Patients with Idiopathic Inflammatory Myopathies

(2015) Yongpeng Ge et al.   PLoS One

A systematic review of statin-induced muscle problems in clinical trials

(2014) Harsha V. Ganga et al.   AMERICAN HEART JOURNAL

Statin-associated Autoimmune Myopathies: A Pathophysiologic Spectrum

(2014) Yufan Wu et al.   CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES

Phenotype Standardization for Statin-Induced Myotoxicity

(2014) A Alfirevic et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Spectrum of statin hepatotoxicity: Experience of the drug-induced liver injury network

(2014) Mark W. Russo et al.   HEPATOLOGY

An assessment by the Statin Muscle Safety Task Force: 2014 update

(2014) Robert S. Rosenson et al.   Journal of Clinical Lipidology

Statins for millions more?

(2014) The Lancet   LANCET

Anti-HMGCR Autoantibodies in European Patients With Autoimmune Necrotizing Myopathies

(2014) Yves Allenbach et al.   MEDICINE

Analysis of Autoantibodies to 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase Using Different Technologies

(2014) Lucile Musset et al.   Journal of Immunology Research

The spectrum of statin myopathy

(2013) Payam Mohassel et al.   CURRENT OPINION IN RHEUMATOLOGY

Exposure assessment of lovastatin in Pu-erh tea

(2013) Zhen-Jun Zhao et al.   INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY

Mechanism of Statin-Induced Rhabdomyolysis

(2013) Kazuho Sakamoto et al.   JOURNAL OF PHARMACOLOGICAL SCIENCES

2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults

(2013) Neil J. Stone et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Antibody levels correlate with creatine kinase levels and strength in anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy

(2012) Jessie L. Werner et al.   ARTHRITIS AND RHEUMATISM

Effect of Statins on Skeletal Muscle Function

(2012) Beth A. Parker et al.   CIRCULATION

3-hydroxy 3-methylglutaryl coenzyme a reductase inhibition impairs muscle regeneration

(2012) Laura Trapani et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Statin myopathy: A common dilemma not reflected in clinical trials

(2011) G. FERNANDEZ et al.   CLEVELAND CLINIC JOURNAL OF MEDICINE

Prevalence and risk factors of muscle complications secondary to statins

(2011) Khalid El-Salem et al.   MUSCLE & NERVE

Rarity of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies in statin users, including those with self-limited musculoskeletal side effects

(2011) Andrew L. Mammen et al.   ARTHRITIS CARE & RESEARCH

A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy

(2010) Lisa Christopher-Stine et al.   ARTHRITIS AND RHEUMATISM

Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy

(2010) Andrew L. Mammen et al.   ARTHRITIS AND RHEUMATISM

3-hydroxy 3-methylglutaryl coenzyme A reductase increase is essential for rat muscle differentiation

(2009) Chiara Martini et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Rhabdomyolysis and Acute Kidney Injury

(2009) Xavier Bosch et al.   NEW ENGLAND JOURNAL OF MEDICINE

SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study

(2008)   NEW ENGLAND JOURNAL OF MEDICINE